Abstract:ABSTRACT Although vaginitis is closely related to vaginal microecology in females, the precise composition and functional potential of different types of vaginitis remain unclear. Here, metagenomic sequencing was applied to analyze the vaginal flora in patients with various forms of vaginitis, including cases with a clue cell proportion ranging from 1% to 20% (Clue1_20), bacterial vaginitis (BV), vulvovaginal candidiasis (VVC), and BV combined with VVC (VVC_BV). Our results identified Prevotella as an important biomarker between BV and Clue1_20. Moreover, a gradual decrease was observed in the relative abundance of shikimic acid metabolism associated with bacteria producing indole as well as a decline in the abundance of Gardnerella vaginalis in patients with BV, Clue1_20, and healthy women. Interestingly, the vaginal flora of patients in the VVC_BV group exhibited structural similarities to that of the VVC group, and its potentially functional characteristics resembled those of the BV and VVC groups. Finally, Lactobacillus crispatus was found in high abundance in healthy samples, greatly contributing to the stability of the vaginal environment. For the further study of L. crispatus , we isolated five strains of L. crispatus from healthy samples and evaluated their capacity to inhibit G. vaginalis biofilms and produce lactic acid in vitro to select the potential probiotic candidate for improving vaginitis in future clinical studies. Overall, we successfully identified bacterial biomarkers of different vaginitis and characterized the dynamic shifts in vaginal flora between patients with BV and healthy females. This research advances our understanding and holds great promise in enhancing clinical approaches for the treatment of vaginitis. IMPORTANCE Vaginitis is one of the most common gynecological diseases, mostly caused by infections of pathogens such as Candida albicans and Gardnerella vaginalis . In recent years, it has been found that the stability of the vaginal flora plays an important role in vaginitis. Furthermore, the abundant Lactobacillus -producing rich lactic acid in the vagina provides a healthy acidic environment such as Lactobacillus crispatus . The metabolites of Lactobacillus can inhibit the colonization of pathogens. Here, we collected the vaginal samples of patients with bacterial vaginitis (BV), vulvovaginal candidiasis (VVC), and BV combined with VVC to discover the differences and relationships among the different kinds of vaginitis by metagenomic sequencing. Furthermore, because of the importance of L. crispatus in promoting vaginal health, we isolated multiple strains from vaginal samples of healthy females and chose the most promising strain with potential probiotic benefits to provide clinical implications for treatment strategies.

Pathogenesis, Diagnosis and Treatment Progress of Bacterial Vaginosis

Molecular Analysis of the Diversity of Vaginal Microbiota Associated with Bacterial Vaginosis

The Female Vaginal Microbiome in Health and Bacterial Vaginosis

Associations Between Vaginal Pathogenic Community And Bacterial Vaginosis In Chinese Reproductive-Age Women

The Restoration of the Vaginal Microbiota after Treatment for Bacterial Vaginosis with Metronidazole or Probiotics

Finding a Balance in the Vaginal Microbiome: How Do We Treat and Prevent the Occurrence of Bacterial Vaginosis?

Biofilm in Bacterial Vaginosis: A Legitimate Therapeutic Challenge?

Review on the etiology of bacterial vaginosis

An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis

Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.

The Prevalence and Risk Factors of Bacterial Vaginosis and Vulvovaginal Candidiasis in Nonpregnant Women

Clinical research on traditional Chinese medicine treatment for bacterial vaginosis

Molecular Analysis of the Relationship Between Specific Vaginal Bacteria and Bacterial Vaginosis Metronidazole Therapy Failure

The Interplay Between Microbiota, Metabolites, Immunity During BV

Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota

Microbial interactions among Gardnerella, Prevotella and Fannyhessea prior to incident bacterial vaginosis: protocol for a prospective, observational study

Predictive Value of the Composition of the Vaginal Microbiota in Bacterial Vaginosis, a Dynamic Study to Identify Recurrence-Related Flora

Non-antibiotic treatment of bacterial vaginosis—a systematic review

Bacterial Vaginosis and Vulvovaginal Candidiasis Pathophysiologic Interrelationship

Treatment of Bacterial Vaginosis: A Comparison of Metronidazole and Clindamycin on Human Anaerobic Bacteria and Lactobacilli

Interpretation of vaginal metagenomic characteristics in different types of vaginitis